KPRX shows concerning financial deterioration with total assets declining by one-third while R&D expenses increased substantially, indicating potential cash burn acceleration.
The company's balance sheet contracted significantly across all major categories, with stockholders' equity falling 37% to $16.1M, suggesting substantial cash consumption during the period. The simultaneous increase in R&D spending to $10.8M while assets shrink indicates an unsustainable burn rate that could threaten the company's ability to fund operations without additional capital raises.
KPRX experienced broad-based balance sheet contraction with total assets declining 34% to $24.3M and stockholders' equity falling to $16.1M. While liabilities also decreased, the company simultaneously increased R&D spending by 38% to $10.8M, creating a concerning mismatch between resource consumption and available capital. The combination of shrinking assets and rising operational expenses suggests accelerating cash burn that warrants close monitoring of the company's liquidity position.
Current liabilities reduced — improved short-term financial position and working capital health.
R&D investment increased 37.5% — signals commitment to future product development, though near-term margin impact.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Total assets contracted 33.5% — asset sales, write-downs, or balance sheet optimization underway.
Interest costs rose 29.5% — monitor debt levels and coverage ratio in rising rate environment.
Current assets declined 26.8% — monitor working capital adequacy and short-term liquidity.
Liabilities reduced 24.2% — deleveraging improves balance sheet strength and financial flexibility.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →